Asutay, MK, Lattarulo, M, Liourdi, D, Al-Aown, AM, Pagonis, K, Nedal, N, Pietropaolo, A, Emiliani, E, Liatsikos, E, Kallidonis, P. Does ureteral access sheath have an impact on ureteral injury. Urology Annals. 2022; 14(1)DOI:10.4103/UA.UA_163_20. PMID:35197695. IF:(Q/D).

Pecoraro A., Andras I., Serni S., Breda A., Boissier R., Campi R., Hevia V., Prudhomme T., Territo A.. The learning curve for open and minimally-invasive kidney transplantation: a systematic review. Minerva Urology And Nephrology. 2022; 74(6)DOI:10.23736/S2724-6051.22.04909-6. PMID:35622352. IF:4.900(Q1/2D).

Lim E.J., Teoh J.Y., Fong K.Y., Emiliani E., Gadzhiev N., Gorelov D., Tanidir Y., Sepulveda F., Al-Terki A., Khadgi S., Mahajan A., Ragoori D., Ramalingam G., Mohan V.C., Ganpule A.P., Kumar S., Castellani D., Monga M., Scoffone C., Vincentini F.C., Traxer O., Somani B.K., Gauhar V.. Propensity score-matched analysis comparing retrograde intrarenal surgery with percutaneous nephrolithotomy in anomalous kidneys. Minerva Urology And Nephrology. 2022; 74(6)DOI:10.23736/S2724-6051.22.04664-X. PMID:35147385. IF:4.900(Q1/2D).

Emiliani E., Quiroz Y.Y., Llorens E., Quintian C., Motta G., Villada D., Bujons A.. Retrorenal colon in pediatric patients with urolithiasis: Is the supine position for PCNL advantageous?. Journal of Pediatric Urology. 2022; 18(6)DOI:10.1016/j.jpurol.2022.07.028. PMID:35985922. IF:2.000(Q3/6D).

Gómez Rivas J., Somani B., Rodriguez Socarrás M., Marra G., Pearce I., Henningsohn L., Zondervan P., Van Poppel H., N'Dow J., Liatsikos E., Palou J.. Shaping the Undergraduate Curriculum in Europe: Consensus Statement from the European School of Urology. EUROPEAN UROLOGY. 2022; 82(6)DOI:10.1016/j.eururo.2022.09.002. PMID:36163308. IF:23.400(Q1/1D).

Rouprêt M., Gontero P., McCracken S.R.C., Dudderidge T., Stockley J., Kennedy A., Rodriguez O., Sieverink C., Vanié F., Allasia M., Witjes J.A., Colombel M., Longo F., Montanari E., Palou J., Sylvester R.J.. Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non–muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker. European Urology Focus. 2022; 8(6)DOI:10.1016/j.euf.2022.02.006. PMID:35300937. IF:5.400(Q1/2D).

Beijert I.J., Hentschel A.E., Bründl J., Compérat E.M., Plass K., Rodríguez O., Subiela Henríquez J.D., Hernández V., de la Peña E., Alemany I., Turturica D., Pisano F., Soria F., Capoun O., Bauerová L., Pešl M., Maxim Bruins H., Runneboom W., Herdegen S., Breyer J., Brisuda A., Calatrava A., Rubio-Briones J., Seles M., Mannweiler S., Bosschieter J., Kusuma V.R.M., Ashabere D., Huebner N., Cotte J., Mertens L.S., Masson-Lecomte A., Liedberg F., Cohen D., Lunelli L., Cussenot O., El Sheikh S., Volanis D., Côté J.-F., Rouprêt M., Haitel A., Shariat S.F., Mostafid A.H., Nieuwenhuijzen J.A., Zigeuner R., Dominguez-Escrig J.L., Hacek J., Zlotta A.R., Burger M., Evert M., Hulsbergen-van de Kaa C.A., van der Heijden A.G., A.L.M. Kiemeney L., Soukup V., Molinaro L., Gontero P., Llorente C., Algaba F., Palou J., N'Dow J., Ribal M.J., van der Kwast T.H., Babjuk M., Sylvester R.J., van Rhijn B.W.G.. T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non–muscle-invasive Bladder Cancer Spectrum. European Urology Focus. 2022; 8(6)DOI:10.1016/j.euf.2022.04.014. PMID:35577750. IF:5.400(Q1/2D).

Bozzini G., Maltagliati M., Berti L., Vismara R., Sanguedolce F., Crisci A., Fiore G.B., Redaelli A., Pastore A.L., Gozen A., Breda A., Scoffone C., Ahmed K., Mueller A., Gidaro S., Liatsikos E.. Development and Validation of a Novel Skills Training Model for PCNL, an ESUT project. Acta Biomedica. 2022; 93(4)DOI:10.23750/abm.v93i4.11821. PMID:36043983. IF:(Q/D).